Shareable Research Card

dMY Squared Technology Group, Inc. Return On Equity

This metric view shows dMY Squared Technology Group, Inc. return on equity history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q4 2025
Latest reported value
90%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 Dec 2025
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q4 2025.
  • Latest reported value on this page: 90%.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Return On Equity

New fact period available

Latest reported return on equity: 90%. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Dec 2025

Page type

Metric history

Latest period

Q4 2025

SEC-backed company facts were refreshed from filings filed on 18 Mar 2026.

Benchmark Context

How Return On Equity compares with peers

dMY Squared Technology Group, Inc. is outside the visible top 120 companies for return on equity in the current sample.

Compared with

Compared with 120 companies reporting return on equity in %. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0.1x the current sample midpoint. Return On Equity is up about 558% versus the comparable prior period.

  • Visible rows currently span reported period ends from 30 Jun 2015 to 31 Mar 2026.
  • Nearby companies in this sample: Savara Inc and Moleculin Biotech, Inc..
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Financial Metric Page

dMY Squared Technology Group, Inc.: Return On Equity

Latest period: Q4 2025. Period end: 31 Dec 2025. Units: %. Frequency: quarterly and annual.

Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

What This Metric Tells You

  • Shows the reported level of return on equity over 31 Dec 2023 - 31 Dec 2025.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 12 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Return On Equity levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Rank Company Latest value Reported period Next step
1 Savara Inc (svra) 58391% Quarter - 31 Mar 2026 Open Savara Inc Return On Equity
2 Moleculin Biotech, Inc. (mbrx) 51267% Quarter - 31 Mar 2026 Open Moleculin Biotech, Inc. Return On Equity
3 Bionik Laboratories Corp. 46191% Quarter - 31 Mar 2023 Open Bionik Laboratories Corp. Return On Equity
4 Athenex, Inc. 25553% Year - 31 Dec 2022 Open Athenex, Inc. Return On Equity
5 Corvex, Inc. (move) 24059% Year - 31 Dec 2025 Open Corvex, Inc. Return On Equity
6 Wenyuan Group Corp. (wygc) 21298% Year - 31 Dec 2025 Open Wenyuan Group Corp. Return On Equity

Metric Details

Metric identity
Taxonomy
ratio
Metric coverage
Units tracked
%
History range
31 Dec 2023 - 31 Dec 2025
Facts on this page
12
How to read it
Metric definition
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
SEC evidence
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

dMY Squared Technology Group, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 90% +76% +558% 01 Oct 2025 31 Dec 2025
Q3 2025 83% +89% 01 Jul 2025 30 Sep 2025
Q2 2025 101% +103% 01 Apr 2025 30 Jun 2025
Q1 2025 67% +99% 01 Jan 2025 31 Mar 2025
Q4 2024 14% +60% 01 Oct 2024 31 Dec 2024
Q3 2024 -5.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -1.7% 01 Apr 2024 30 Jun 2024
Q1 2024 -32% 01 Jan 2024 31 Mar 2024
Q4 2023 -47% 01 Oct 2023 31 Dec 2023

dMY Squared Technology Group, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 90% +76% +558% 01 Jan 2025 31 Dec 2025
2024 14% +60% 01 Jan 2024 31 Dec 2024
2023 -47% 01 Jan 2023 31 Dec 2023
* indicates a reported value that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .